摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,2,5-trimethyl-3-[1-(4-bromophenyl)ethoxy]-4-phenyl-3-azahexane | 293328-14-0

中文名称
——
中文别名
——
英文名称
2,2,5-trimethyl-3-[1-(4-bromophenyl)ethoxy]-4-phenyl-3-azahexane
英文别名
2,2,5-trimethyl-3-(1'-(p-bromo)phenylethoxy)-4-phenyl-3-azahexane;N-[1-(4-bromophenyl)ethoxy]-N-tert-butyl-2-methyl-1-phenylpropan-1-amine
2,2,5-trimethyl-3-[1-(4-bromophenyl)ethoxy]-4-phenyl-3-azahexane化学式
CAS
293328-14-0
化学式
C22H30BrNO
mdl
——
分子量
404.39
InChiKey
MWIVUAXBGYATAD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    452.8±55.0 °C(Predicted)
  • 密度:
    1.166±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    6.7
  • 重原子数:
    25
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    12.5
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:86556f3a7e6744b7a0663f0f961d6f83
查看

反应信息

  • 作为产物:
    参考文献:
    名称:
    Synthesis of a Conjugated Macromolecular Initiator for Nitroxide-Mediated Free Radical Polymerization
    摘要:
    Controlled synthesis of rod-coil block copolymers is possible with a new macroinitiator for "living" nitroxide-mediated radical polymerization (NMRP). The synthesis of the new macroinitiator which contains a rodlike, conjugated poly(p-phenylene vinylene) block is described. Electron microscopy imaging indicates microphase separation of the resulting block copolymer when cast from chloroform.
    DOI:
    10.1002/1521-3773(20010119)40:2<428::aid-anie428>3.0.co;2-n
点击查看最新优质反应信息

文献信息

  • DENDRITIC MOLECULAR INTRACELLULAR TRANSPORTERS AND METHODS OF MAKING AND USING SAME
    申请人:Harth Eva M.
    公开号:US20080221043A1
    公开(公告)日:2008-09-11
    In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure: and at least one guanidinium residue, wherein m is zero or a positive integer. Also disclosed are methods of preparing the disclosed compounds. Also disclosed are methods of intracellular delivery comprising administering the disclosed compounds and compositions to a subject. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of one or more compounds or compositions of the invention and a pharmaceutically acceptable carrier. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    根据本发明的目的,本发明在一个方面涉及包含以下结构的化合物,以及至少一个鸟氨酸残基,其中m为零或正整数。还公开了制备所述化合物的方法。还公开了包括将所述化合物和组合物给予受试者的细胞内递送方法。还公开了包括本发明的一个或多个化合物或组合物的治疗有效量和药学可接受载体的制药组合物。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。
  • MULTIFUNCTIONAL DEGRADABLE NANOPARTICLES WITH CONTROL OVER SIZE AND FUNCTIONALITIES
    申请人:Harth Eva M.
    公开号:US20090306335A1
    公开(公告)日:2009-12-10
    In one aspect, the invention relates to polymers, crosslinked polymers, functionalized polymers, nanoparticles, and functionalized nanoparticles and methods of making and using same. In one aspect, the invention relates to degradable polymer and degradable nanoparticles. In one aspect, the invention relates to methods of preparing degradable nanoparticles and, more specifically, methods of controlling particle size during the preparation of degradable nanoparticles. In one aspect, the degradable nanoparticles are useful for complexing, delivering, and releasing payloads, including pharmaceutically active payloads. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    本发明涉及聚合物、交联聚合物、功能化聚合物、纳米颗粒和功能化纳米颗粒以及其制备和使用方法。其中,本发明涉及可降解聚合物和可降解纳米颗粒。本发明还涉及制备可降解纳米颗粒的方法,更具体地说,涉及在制备可降解纳米颗粒过程中控制颗粒大小的方法。在一方面,这些可降解纳米颗粒可用于复合、传递和释放药物活性载荷等方面。本摘要旨在作为搜索特定技术领域的扫描工具,不限制本发明。
  • Multifunctional Degradable Nanoparticles with Control over Size and Functionalities
    申请人:Harth Eva M.
    公开号:US20110257343A1
    公开(公告)日:2011-10-20
    In one aspect, the invention relates to polymers, crosslinked polymers, functionalized polymers, nanoparticles, and functionalized nanoparticles and methods of making and using same. In one aspect, the invention relates to degradable polymer and degradable nanoparticles. In one aspect, the invention relates to methods of preparing degradable nanoparticles and, more specifically, methods of controlling particle size during the preparation of degradable nanoparticles. In one aspect, the degradable nanoparticles are useful for complexing, delivering, and releasing payloads, including pharmaceutically active payloads. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    一方面,本发明涉及聚合物、交联聚合物、功能化聚合物、纳米颗粒和功能化纳米颗粒的制备和使用方法。另一方面,本发明涉及可降解聚合物和可降解纳米颗粒。另一方面,本发明涉及制备可降解纳米颗粒的方法,更具体地说,涉及在制备可降解纳米颗粒过程中控制颗粒大小的方法。另一方面,可降解纳米颗粒可用于复合、传递和释放药物活性载荷等用途。本摘要旨在作为搜索特定领域的扫描工具,不限制本发明。
  • Dendritic Molecular Intracellular Transporters and Methods of Making and Using Same
    申请人:Vanderbilt University
    公开号:US20150315174A1
    公开(公告)日:2015-11-05
    In accordance with the purpose(s) of the invention, as embodied and broadly described herein, the invention, in one aspect, relates to compounds comprising the structure: and at least one guanidinium residue, wherein m is zero or a positive integer. Also disclosed are methods of preparing the disclosed compounds. Also disclosed are methods of intracellular delivery comprising administering the disclosed compounds and compositions to a subject. Also disclosed are pharmaceutical compositions comprising a therapeutically effective amount of one or more compounds or compositions of the invention and a pharmaceutically acceptable carrier. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    根据本发明的目的,本发明在一个方面涉及包含以下结构和至少一个鸟氨酸残基的化合物,其中m为零或正整数。还揭示了制备所述化合物的方法。还揭示了通过向受体注射所述化合物和组合物的方法进行细胞内递送。还揭示了含有本发明一种或多种化合物或组合物的治疗有效量和药学上可接受的载体的制药组合物。本摘要旨在用于搜索特定领域的扫描工具,不限制本发明。
  • Synthesis of a Bifunctional Initiator for Controlled Kumada Catalyst-Transfer Polycondensation/Nitroxide-Mediated Polymerization and Preparation of Poly(3-hexylthiophene)−Polystyrene Block Copolymer Therefrom
    作者:Elisabeth Kaul、Volodymyr Senkovskyy、Roman Tkachov、Vera Bocharova、Hartmut Komber、Manfred Stamm、Anton Kiriy
    DOI:10.1021/ma902354j
    日期:2010.1.12
    Herein, we present a new approach to synthesize rod-coil block copolymers via consecutive Kumada catalyst-transfer polycondensation (KCTP) and nitroxide-mediated free radical polymerization (NMP) performed from a bifunctional initiator, TIPNO-Ph-Ni(dppp)-Br (TIPNO = 2,2,5-trimethyl-4-phenyl-3-azahexane-3-nitroxide; dppp = propane-1,3-diylbis(diphenylphosphane). The Utility Of the method was exemplified in a preparation of a model block copolymer, poly(3-hexylthiophene)-block-polystyrene (P3HT-b-PS) with a relatively narrow molecular weight distribution of 1.33. Synthesis of the bifunctional initiator was accomplished by a reaction of diethylbipyridylnickel with a readily accessible Precursor. TIPNO-Ph-Br, followed by ill situ replacement of the bipyridyl ligand onto bidentate phosphorus one.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫